Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging therapeutic targets for cardiac hypertrophy
Alexander J. Winkle, Drew Nassal, Rebecca Shaheen, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 1, pp. 29-40
Open Access | Times Cited: 21

Showing 21 citing articles:

20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca2+ signaling in H9c2 cells
Jingyi Han, Jiaojiao Li, Lianlian Liu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Astragali Radix−Notoginseng Radix et Rhizoma medicine pair prevents cardiac remodeling by improving mitochondrial dynamic balance
Pingping Lin, Hong Chen, Zekun Cui, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 54-63
Closed Access | Times Cited: 1
Reduced DNMT1 levels induce cell apoptosis via upregulation of METTL3 in cardiac hypertrophy
Xidong Zhang, Yanhua Nie, Rui Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24572-e24572
Open Access | Times Cited: 4
Contributing role and molecular basis of Vitamin D/Vitamin D receptor deficiency in hyperhomocysteinemia-induced cardiac hypertrophy
Hang Qi, Yang Zhou, Hai‐Tao Hou, et al.
Biochemical Pharmacology (2025), pp. 116812-116812
Closed Access
Regulatory mechanism of CaMKII δ mediated by RIPK3 on myocardial fibrosis and reversal effects of RIPK3 inhibitor GSK'872
Jingjing Zhang, Ji Cao, Jianan Qian, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115380-115380
Open Access | Times Cited: 10
Usp20 deletion promotes eccentric cardiac remodeling in response to pressure overload and increases mortality
Pierre‐Yves Jean‐Charles, Bipradas Roy, Samuel Mon-Wei Yu, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 327, Iss. 5, pp. H1257-H1271
Closed Access | Times Cited: 3
Virtual drug screen reveals context‐dependent inhibition of cardiomyocyte hypertrophy
Taylor G. Eggertsen, Jeffrey J. Saucerman
British Journal of Pharmacology (2023) Vol. 180, Iss. 21, pp. 2721-2735
Open Access | Times Cited: 6
Gramine protects against pressure overload-induced pathological cardiac hypertrophy through Runx1-TGFBR1 signaling
Longwei Xu, Yuanyuan Su, Xiaolin Yang, et al.
Phytomedicine (2023) Vol. 114, pp. 154779-154779
Closed Access | Times Cited: 5
Finding New Targets for the Treatment of Heart Failure: Endoplasmic Reticulum Stress and Autophagy
Leilei Hu, Dongjie Gao, Hao Lv, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 16, Iss. 6, pp. 1349-1356
Closed Access | Times Cited: 5
PKD knockdown mitigates Ang II-induced cardiac hypertrophy and ferroptosis via the JNK/P53 signaling pathway
Chanyuan Lv, Liuyi Zhou, Yongkang Meng, et al.
Cellular Signalling (2023) Vol. 113, pp. 110974-110974
Open Access | Times Cited: 5
Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway
Kelian Zhang, Huilin Zhuo, Jingyi Guo, et al.
International Heart Journal (2024) Vol. 65, Iss. 1, pp. 119-127
Open Access | Times Cited: 1
Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy
David Aluja, Sara Delgado-Tomás, Marisol Ruiz‐Meana, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4103-4103
Open Access | Times Cited: 7
The mechanism of 14-3-3η in thyroxine induced mitophagy in cardiomyocytes
Yalan Cui, Yan Zhang, Songsong Dai, et al.
Molecular and Cellular Endocrinology (2024) Vol. 590, pp. 112271-112271
Closed Access | Times Cited: 1
Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response
Paramjit S. Tappia, Naranjan S. Dhalla
Cells (2022) Vol. 11, Iss. 16, pp. 2488-2488
Open Access | Times Cited: 5
Upregulation of key genes Eln and Tgfb3 were associated with the severity of cardiac hypertrophy
Rui Zhang, Xuan Xu, Xi Chen, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Myocardial delivery of miR30d with peptide-functionalized milk-derived extracellular vesicles for targeted treatment of hypertrophic heart failure
Lingjun Tong, Qiyue Wang, Yameng Zhang, et al.
Biomaterials (2024) Vol. 316, pp. 122976-122976
Closed Access
Circular RNA circFTO promotes pressure overload-induced cardiac hypertrophy via encoding a novel protein FTO-36aa
Qirong Xu, Jinlong Liu, Zhibo Liu, et al.
Research Square (Research Square) (2024)
Open Access
Role of Cathelicidins in Atherosclerosis and Associated Cardiovascular Diseases
Siarhei A. Dabravolski, Nikolay A. Orekhov, Alexey V. Churov, et al.
Journal of Molecular Pathology (2024) Vol. 5, Iss. 3, pp. 319-334
Open Access
Role of phospholipase C in catecholamine-induced increase in myocardial protein synthesis
Paramjit S. Tappia, Bram Ramjiawan, Naranjan S. Dhalla
Canadian Journal of Physiology and Pharmacology (2022) Vol. 100, Iss. 10, pp. 945-955
Closed Access | Times Cited: 2
Effects of Obesity and Diabesity on Ventricular Muscle Structure and Function in the Zucker Rat
Ahmed Sultan, Ernest Adeghate, Bright Starling Emerald, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1221-1221
Open Access | Times Cited: 1
LEFT VENTRICULAR REMODELING IN HEART FAILURE (PART ІI): PHENOTYPIC HETEROGENEITY AS A RATIONALE FOR PERSONALIZED PATIENTS` MANAGEMENT
T.Ya. Chursina, А.М. Kravchenko, К.О. Міхалєв
Clinical and Preventive Medicine (2023), Iss. 3, pp. 20-32
Open Access
Page 1

Scroll to top